产品介绍 评论(0)
物种
Human分子别名
TP53, P53, Phosphoprotein p53, Tumor suppressor p53Accession
P04637表达序列
S94-T312, Y220C with His Tag at the N-Terminus
表达宿主
E.coli分子量
25-35kDa (Reducing)纯度
>95% by SDS-PAGE & HPLC标记
Unconjugated标签
His Tag性状
Liquid缓冲体系
50mM Tris, 150mM NaCl, pH7.5, 1mM DTT, 10%Glycerol
储存条件
Stable for 12 months upon stored at -80℃ from the date of receipt. And avoid repeated freeze-thaws cycles.
文献引用
1. Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator. Cancer Discovery, 15(6), 1159-1179.2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
3. Lane, D.P. (1992). Cancer. p53, guardian of the genome. Nature, 358(6381), 15-16.
P53-Y220C is one of the most representative conformational mutants of the TP53 gene, resulting from a substitution of tyrosine to cysteine at position 220. This mutation is located on the surface of the DNA-binding domain (DBD) and does not directly participate in DNA contact. The Y220C mutation creates a surface crevice or “pocket” within the protein core, severely disrupting the thermodynamic stability of the p53 protein. This causes it to undergo conformational changes and aggregate at physiological temperatures, leading to a loss of DNA-binding ability and transcriptional activation function.
In contrast to many other types of mutations, the unique crevice created by the Y220C mutation provides an excellent “druggable” target for the development of small-molecule “chaperone” drugs. These small molecules can precisely bind to this crevice, acting like “glue” to stabilize the folded conformation of the p53 protein, thereby restoring its tumor suppressor function. Consequently, P53-Y220C has become one of the most intensively studied and advanced mutation targets in the field of p53-targeted therapeutics.
电泳
2μg (R: reducing condition, N: non-reducing condition).
反相高效液相色谱(RP-HPLC)
The purity of P53(Y220C) His Tag Protein, Human is more than 95% determined by RP-HPLC.







评论(0)